Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“in preparation for launching a Phase 3 trial within a year”
· From the Desk of Rick Doblin, Ph.D. – June 2022 (MAPS Bulletin) · own post

MAPS will launch a European Phase 3 MDMA trial by mid-2023.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.